2019 Hong Kong IPO Analytics: How Did Insti and Retail Coverage Impact Deal Performance
Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...
723 Views
Jiumaojiu (九毛九) Trading - Off to a Great Start with 638x Oversubscription
Jiumaojiu (9922 HK) raised about US$283m at HK$6.60 per share, the top end of its IPO price range. We have previously covered the IPO...
683 Views
ECM Weekly (9 Nov 2019) - Phoenix Tree, I-Mab, Tyro Payments, Pharmaron, Heaven-Sent
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong Kong...
900 Views
Shanghai Kindly (康德莱医疗) Post-IPO Trading: What's Next After a Stella Debut Performance
Shanghai Kindly's (KDL Medical) IPO was priced at the high end and started trading today. We have highlighted in our earlier note that 1) the...
557 Views
Shanghai Kindly (康德莱医疗) IPO - Cardiovascular Device Leader Backed by Strong Cornerstone
Shanghai Kindly Medical Instrument is a leading domestic player in the cardiovascular interventional device market, particularly the Percutaneous...
701 Views